DK0591605T3 - Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin - Google Patents

Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin

Info

Publication number
DK0591605T3
DK0591605T3 DK93104123T DK93104123T DK0591605T3 DK 0591605 T3 DK0591605 T3 DK 0591605T3 DK 93104123 T DK93104123 T DK 93104123T DK 93104123 T DK93104123 T DK 93104123T DK 0591605 T3 DK0591605 T3 DK 0591605T3
Authority
DK
Denmark
Prior art keywords
serum albumin
human serum
suppressing staining
staining
suppressing
Prior art date
Application number
DK93104123T
Other languages
English (en)
Inventor
Akinori Sumi
Wataru Ohtani
Naoto Furuhata
Kazuya Takeshima
Kaeko Kamide
Takao Ohmura
Kazumasa Yokoyama
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14031724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0591605(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of DK0591605T3 publication Critical patent/DK0591605T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK93104123T 1992-03-16 1993-03-13 Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin DK0591605T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4091624A JPH07102147B2 (ja) 1992-03-16 1992-03-16 ヒト血清アルブミンの着色抑制方法

Publications (1)

Publication Number Publication Date
DK0591605T3 true DK0591605T3 (da) 2001-01-29

Family

ID=14031724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93104123T DK0591605T3 (da) 1992-03-16 1993-03-13 Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin

Country Status (9)

Country Link
US (1) US5369020A (da)
EP (1) EP0591605B2 (da)
JP (1) JPH07102147B2 (da)
KR (1) KR0168689B1 (da)
CA (1) CA2091636C (da)
DE (1) DE69329841T3 (da)
DK (1) DK0591605T3 (da)
ES (1) ES2152935T5 (da)
TW (1) TW255914B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
CA2136564C (en) * 1993-11-26 2008-04-08 Kaoru Kobayashi Process for producing human serum albumin
DK0658569T3 (da) * 1993-12-17 2005-02-07 Mitsubishi Pharma Corp Fremgangsmåde til affarvning af humant serumalbumin
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
JPH0823995A (ja) * 1994-07-14 1996-01-30 Green Cross Corp:The 宿主細胞由来のプロテアーゼで低分子化され得る蛋白質の製造方法
CA2157219C (en) * 1994-08-31 2010-10-05 Munehiro Noda Process for purifying recombinant human serum albumin
US20130281355A1 (en) * 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
CA2903596C (en) * 2013-03-15 2023-10-03 Genentech, Inc. Cell culture compositions with antioxidants and methods for polypeptide production
TW202330904A (zh) 2015-08-04 2023-08-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054489A (en) * 1975-09-26 1977-10-18 Nelli Isaakovna Zhdanova Method of preparing l-glutamic acid and its sodium salt
US4165258A (en) * 1975-10-08 1979-08-21 University Of Pennsylvania Plasminogen activating enzyme-specific competitive inhibitor
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
FR2594846B1 (fr) * 1986-02-21 1989-10-20 Genetica Procede de preparation de la serum albumine humaine mature
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
JPH03262487A (ja) * 1990-03-12 1991-11-22 Tonen Corp ヒト血清アルブミンの安定な製造方法
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
EP0591605B1 (en) 2001-01-10
DE69329841D1 (de) 2001-02-15
JPH05260986A (ja) 1993-10-12
ES2152935T3 (es) 2001-02-16
CA2091636C (en) 2004-02-03
DE69329841T2 (de) 2001-05-31
US5369020A (en) 1994-11-29
KR0168689B1 (ko) 1999-01-15
EP0591605A2 (en) 1994-04-13
JPH07102147B2 (ja) 1995-11-08
ES2152935T5 (es) 2007-05-16
EP0591605A3 (da) 1994-04-20
CA2091636A1 (en) 1993-09-17
KR930019817A (ko) 1993-10-19
TW255914B (da) 1995-09-01
DE69329841T3 (de) 2007-06-21
EP0591605B2 (en) 2006-11-15

Similar Documents

Publication Publication Date Title
DK0570916T3 (da) Fremgangsmåde til rensning af humant rekombinant serumalbumin
DK0464590T3 (da) Hindring af farvning af humant serumalbumin
DK0564505T3 (da) Administrationsform til mikroblæreekkokontrastmidler
DK0699687T3 (da) Fremgangsmåde til oprensning af rekombinant humant serumalbumin
DK42093D0 (da) Administrationsmetode
DE69329764D1 (de) Neues kosmetisches präparat
IS1752B (is) Bætt aðferð við tilurð omeprazole
DK0861089T3 (da) Metoder og sammensætninger til indgivelse af monomere proteiner
FI905124A0 (fi) Menetelmä pyrimidiinien valmistamiseksi
DK0420007T3 (da) Fremgangsmåde til rensning af human serumalbumin
DK38293D0 (da) Fremstilling af proteiner
DK125789D0 (da) Fremgangsmaade til kontinuerlig forestring af fedtsyre
KR920700043A (ko) 알부민 제제 및 이의 제조방법
EE03048B1 (et) Meetod lovastatiini valmistamiseks
DK453789A (da) Fremgangsmaade til paavirkning af azopigmenters triboelektriske effekt
DK0591605T3 (da) Fremgangsmåde til undertrykkelse af farvning af humant serumalbumin
DK0656419T3 (da) Fremgangsmåde til højrensning af humant serumalbumin
DE59303475D1 (de) Stimmprothese
DK0504823T3 (da) Fremgangsmåde til fremstilling af human serumalbumin
DK14589A (da) Fremgangsmaade til fremstilling af 1-alkyl-5-nitroimidazoler
DK249090A (da) Anvendelse af glycoproteiner til fremstilling af haarpraeparater
DK0655503T3 (da) Fremgangsmåde til fremstilling af humant serumalbumin
DK82592D0 (da) Fremstilling af proteiner
DK0899262T3 (da) Fremgangsmåde til fremstilling af heteroarylcarboxylamider og -estere
DK0658569T3 (da) Fremgangsmåde til affarvning af humant serumalbumin